Ainos (AIMD) Competitors $3.48 -0.03 (-0.85%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock AIMD vs. APLT, INCR, VNRX, QNTM, ARTV, ANL, PRLD, GANX, KPTI, and CLNNShould you be buying Ainos stock or one of its competitors? The main competitors of Ainos include Applied Therapeutics (APLT), InterCure (INCR), VolitionRx (VNRX), Quantum Biopharma (QNTM), Artiva Biotherapeutics (ARTV), Adlai Nortye (ANL), Prelude Therapeutics (PRLD), Gain Therapeutics (GANX), Karyopharm Therapeutics (KPTI), and Clene (CLNN). These companies are all part of the "pharmaceutical products" industry. Ainos vs. Its Competitors Applied Therapeutics InterCure VolitionRx Quantum Biopharma Artiva Biotherapeutics Adlai Nortye Prelude Therapeutics Gain Therapeutics Karyopharm Therapeutics Clene Ainos (NASDAQ:AIMD) and Applied Therapeutics (NASDAQ:APLT) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability. Which has better valuation and earnings, AIMD or APLT? Ainos has higher earnings, but lower revenue than Applied Therapeutics. Applied Therapeutics is trading at a lower price-to-earnings ratio than Ainos, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAinos$20K810.84-$14.86M-$4.99-0.70Applied Therapeutics$460K388.20-$105.62M-$0.45-2.76 Do analysts prefer AIMD or APLT? Applied Therapeutics has a consensus price target of $4.13, indicating a potential upside of 232.66%. Given Applied Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Applied Therapeutics is more favorable than Ainos.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ainos 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Applied Therapeutics 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40 Do institutionals & insiders have more ownership in AIMD or APLT? 98.3% of Applied Therapeutics shares are owned by institutional investors. 10.4% of Ainos shares are owned by company insiders. Comparatively, 1.6% of Applied Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more volatility & risk, AIMD or APLT? Ainos has a beta of 2.25, indicating that its stock price is 125% more volatile than the S&P 500. Comparatively, Applied Therapeutics has a beta of 2.06, indicating that its stock price is 106% more volatile than the S&P 500. Is AIMD or APLT more profitable? Ainos' return on equity of -108.25% beat Applied Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets AinosN/A -108.25% -56.94% Applied Therapeutics N/A -354.24%-144.16% Does the media refer more to AIMD or APLT? In the previous week, Applied Therapeutics had 1 more articles in the media than Ainos. MarketBeat recorded 2 mentions for Applied Therapeutics and 1 mentions for Ainos. Ainos' average media sentiment score of 1.89 beat Applied Therapeutics' score of 0.95 indicating that Ainos is being referred to more favorably in the media. Company Overall Sentiment Ainos Very Positive Applied Therapeutics Positive SummaryAinos beats Applied Therapeutics on 8 of the 15 factors compared between the two stocks. Get Ainos News Delivered to You Automatically Sign up to receive the latest news and ratings for AIMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AIMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIMD vs. The Competition Export to ExcelMetricAinosMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.22M$2.50B$5.67B$10.37BDividend YieldN/A54.21%5.75%4.64%P/E Ratio-0.7023.4875.8426.15Price / Sales810.84725.32561.11125.41Price / CashN/A176.2437.6061.28Price / Book0.635.1612.396.35Net Income-$14.86M$32.95M$3.29B$271.10M7 Day Performance-7.45%2.23%1.22%0.29%1 Month Performance-15.33%6.11%3.77%6.26%1 Year Performance31.74%2.01%60.92%28.33% Ainos Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIMDAinos1.2913 of 5 stars$3.48-0.9%N/A+23.2%$16.22M$20K-0.7040Positive NewsAPLTApplied Therapeutics3.81 of 5 stars$0.47+3.1%$4.13+781.4%-93.3%$67.25M$460K-1.0430Gap UpINCRInterCure0.4629 of 5 stars$1.46+0.7%N/A-23.0%$66.58M$238.85M0.00350VNRXVolitionRx1.5599 of 5 stars$0.61+0.1%$3.50+477.6%-2.7%$65.31M$1.32M-1.6980QNTMQuantum Biopharma0.3747 of 5 stars$17.39-5.3%N/A+349.2%$64.91MN/A-1.21N/AARTVArtiva Biotherapeutics3.2271 of 5 stars$2.64+1.9%$17.00+543.9%-80.1%$64.50M$250K0.0081ANLAdlai Nortye1.9466 of 5 stars$1.75-2.5%$9.00+415.8%-17.6%$64.39M$5M0.00127Positive NewsGap DownPRLDPrelude Therapeutics3.4368 of 5 stars$1.13+9.2%$4.00+255.6%-41.3%$63.68M$7M-0.69120News CoveragePositive NewsAnalyst ForecastAnalyst RevisionGANXGain Therapeutics2.681 of 5 stars$1.74-0.6%$8.00+359.8%-2.8%$62.55M$50K-2.7620Positive NewsGap UpKPTIKaryopharm Therapeutics3.6992 of 5 stars$7.20-3.8%$34.00+372.6%-36.3%$62.38M$145.24M-0.49380CLNNClene3.1706 of 5 stars$6.12flat$32.60+432.7%+26.2%$61.63M$340K-1.63100News CoverageAnalyst ForecastGap Down Related Companies and Tools Related Companies APLT Competitors INCR Competitors VNRX Competitors QNTM Competitors ARTV Competitors ANL Competitors PRLD Competitors GANX Competitors KPTI Competitors CLNN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AIMD) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredThis is the “End of Tesla” as we know it…Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ainos, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ainos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AIMD Stock Alerts